The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSunrise Res Regulatory News (SRES)

Share Price Information for Sunrise Res (SRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0575
Bid: 0.05
Ask: 0.065
Change: 0.01 (21.05%)
Spread: 0.015 (30.00%)
Open: 0.0475
High: 0.0575
Low: 0.0475
Prev. Close: 0.0475
SRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HALF-YEARLY REPORT 2022

24 May 2022 14:00

RNS Number : 6322M
Sunrise Resources Plc
24 May 2022
 

 

24 May 2022SUNRISE RESOURCES PLC

("Sunrise" or the "Company")

 

HALF-YEARLY REPORT 2022

 

 

Sunrise Resources plc, the AIM-traded company focusing on the development of its CS Pozzolan-Perlite Project in Nevada, USA, announces its unaudited interim results for the six months ended 31 March 2022, a copy of which is also available on the Company's website, www.sunriseresourcesplc.com

 

Operational Highlights

 

CS Pozzolan-Perlite Project

 

 

Ø Discussions continuing for project development with cement and concrete industry participants. Recent meetings held with multiple parties, including:

two cement & ready-mix companies,

a major fly ash distributor,

a large building materials company and

a new cement clean-tech company.

 

Ø Application made for conditional approval of CS natural pozzolan for Caltrans's Authorized Materials List as supplementary cementitious materials ("SCMs") mandated in California State infrastructure projects to build more durable and sustainable concrete structures.

 

Ø Natural pozzolan has a key role in cement decarbonisation strategies towards net-zero CO2 emissions and is expected to benefit from recent California State legislation and Implementation Priorities under President Biden's $1.2 trillion Infrastructure Bill.

 

Ø Company prioritising pozzolan over perlite in production strategies as deposits and markets are larger.

 

Hazen Pozzolan Project

 

Ø Industry interest extended to Hazen Pozzolan Project. Due diligence field visits carried out by interested parties and further sample testing underway.

 

Ø Permit obtained to extract 500ton sample for commercial trials.

 

Pioche Sepiolite Project, Nevada

 

Ø Positive test-work results reported by European industrial minerals company from testing of high grade sepiolite samples in Europe.

 

Ø Discussions being held with interested parties facilitated by sepiolite specialist.

 

Myrtle Gold Silver project, Nevada

 

Ø High grade gold and silver results from sampling at Myrtle Gold-Silver project from potential intrusion related gold system.

 

Baker's Gold Project, Western Australia

 

Ø Mining lease application submitted to cover high-grade gold mineralisation intersected in 2021 drill programme.

 

 

 

 

 

Financial Results Summary

 

Group loss for the six-months ended 31 March 2022 of £153,323 (31 March 2021: £185,955) comprising:

 

· Revenue income from lease of £11,422.

 

· Interest income of £11; less Administration costs of £160,623.

 

· Expensed pre-licence exploration costs totalling £4,133.

 

Project expenditure of £37,145 was capitalised.

 

 

Funding during the period

 

No equity or other funds were raised during the current reporting period except for a small amount raised through the exercise of warrants (£675). Shares to the value of £16,685 were issued in January 2022 in satisfaction of a portion of outstanding directors' fees.

 

At 31 March 2022, the Company held £183,923 in cash and cash equivalents and liquid listed investments having a value of £49,553.

 

The Company relies upon periodic capital fundraisings until such time as cashflow can be derived either from the sale of assets or future operations.

 

 

Further information:

 

Sunrise Resources plc

Patrick Cheetham, Executive Chairman

Tel: +44 (0)1625 838 884

 

Beaumont Cornish Limited

Nominated Adviser

James Biddle/Roland Cornish

Tel: +44 (0)207 628 3396

 

Peterhouse Capital Limited

Broker

Lucy Williams/Duncan Vasey

Tel: +44 (0)207 469 0930

 

 

 

CAUTIONARY NOTICE

The news release may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's directors. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such forward-looking statements. Accordingly, you should not rely on any forward-looking statements and save as required by the AIM Rules for Companies or by law, the Company does not accept any obligation to disseminate any updates or revisions to such forward-looking statements.

 

MARKET ABUSE REGULATION (MAR) DISCLOSURE

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

Chairman's Statement

 

I am pleased to present the Company's unaudited financial results for the six-months' period ended 31 March 2022.

 

In this period, management has concentrated on advancing our CS Pozzolan-Perlite Project in Nevada in line with the strategy last outlined in our 2021 Annual Report. This strategy allows for a number of production scenarios for both natural pozzolan and perlite. The production of natural pozzolan is the larger

business opportunity for the Company as our deposits are larger, the markets in cement and concrete are potentially large and, not least, because perlite can also be used as a natural pozzolan. Consequently, our efforts to find a partner to develop the CS Project have focused on the cement and concrete industries.

 

During the period, therefore, we have continued negotiations with potential industry partners and with one cement and ready-mix company ("CRMC") in particular following a successful joint bulk sampling, test milling and concrete pouring programme in 2021. However, further negotiations with this CRMC were recently terminated having become protracted without reaching a satisfactory conclusion in significant part due to organisational changes within the CRMC.

 

Since then, we have been able to build on the successful 2021 commercial trials and we are advancing discussions with a number of other existing and new interested parties. Indeed, we are seeing an upsurge of interest in natural pozzolan, not just from the traditional cement and concrete companies, but also from the building materials companies that supply to those companies, as well as new generation clean-tech cement companies developing new types of carbon-neutral cements and concretes using natural pozzolans in their formulations.

 

Cement production is responsible for 8% of global man-made CO2 emissions and much has already been said about the huge environmental challenges faced by the cement and concrete industries which are tasked by legislation and industry targets to achieve net-zero CO2 emissions by 2050. Several strategies are being employed to achieve these targets including the use of supplementary cementitious materials ("SCMs") such as natural pozzolan in blended cements.

 

The manufacture of pozzolan blended cements allows cement companies to reduce the embodied carbon in their products. It also increases their cement production per ton of cement clinker capacity at a time when they are already operating at full capacity and cement process are soaring.

 

The use of SCMs has crossover to other decarbonisation strategies, as SCMs alone have the additional benefit that they increase the long-term durability and sustainability of concrete by mitigating concrete cancer. It also seems likely that priority will be given to greener and more sustainable building materials in contracts awarded under the Implementation Policies of Biden's $1.2 trillion Infrastructure Bill.

 

We are targeting the California markets with our CS natural pozzolan where a significant consumer of concrete in California is the State Government Department of Transport ("Caltrans"). Caltrans mandates the use of SCMs from its Authorised List for State funded infrastructure projects to improve the durability and sustainability of its structures. We have applied to Caltrans for conditional approval of CS Pozzolan onto this list under a new procedure for new sources of supply. Acceptance onto this list is also important as it is an endorsement of quality for independent concrete specifiers.

 

Our strategy for our perlite deposits is to align the production with natural pozzolan as the production of coarse horticultural grades of perlite produces perlite fines which can be sold as natural pozzolan. Our strategy also provides for a stand-alone perlite plant in due course where both coarse and fine grades of perlite are directed to perlite specific applications. To that end we have started work to find markets for the finer grades of perlite in its traditional industrial applications where its property to expand on heating is required.

 

In 2021, we acquired a second natural pozzolan project, at Hazen in northern Nevada as we seek to expand our interests into other regional centres of cement and concrete demand, in this case northern Nevada and northern California. Although at an early stage, and the extent of the deposit is yet to be defined, this project is also attracting industry interest and due diligence field visits have recently been conducted to both Hazen and the CS Projects. A permit has been obtained from the US Bureau of Land Management for a 500 ton bulk sample to be extracted at Hazen for commercial scale testing. 

 

Our activities on other projects in the reporting period has been limited as we have sought to preserve existing cash resources from our last placing in August 2020. We have, however, carried out a small mapping and sampling programme on our Myrtle Project in Nevada where high-grade gold and silver results have recently been announced in a potential intrusion related gold system and further exploration is justified.

 

At our Pioche Sepiolite Project in Nevada, an extended programme of industrial test-work being conducted by a European industrial minerals producer has now concluded and is reported to have produced positive results from high grade samples collected during a joint field visit in December 2021. Discussions are being held with interested parties facilitated by a sepiolite industry specialist working on a success-based fee.

 

In Western Australia we have also applied for a mining lease to cover the high-grade gold mineralisation intersected in drilling last year at our Baker's gold project. If granted this will extend our tenure over this project beyond the expiry of our underlying prospecting licences and we have submitted a programme of work to the Department of Mines to allow for follow up drilling.

 

I think there is much to look forward to in the remainder of the financial year. We hold one of the few fully permitted and undeveloped natural pozzolan deposits in the western US, momentum is building for natural pozzolan, and we believe our CS and Hazen Pozzolan Projects are well placed to help industry in pursuit of its net-zero goals. In addition, we have a largely overlooked but valuable portfolio of precious and base metal projects that can provide additional growth opportunities in future.

 

 

 

 

Patrick Cheetham

Executive Chairman

24 May 2022

 

 

 

 

Consolidated Income Statement

for the six months to 31 March 2022

 

 

 

Six months

to 31 March

2022

Unaudited

 

Six months

to 31 March

2021

Unaudited

 

 

Twelve months to

30 September

2021

Audited

 

£

£

£

 

 

Revenue

11,422

-

-

 

 

 

Pre-licence exploration costs

(4,133)

(12,985)

(17,320)

 

 

Impairment of deferred exploration assets

-

(7,428)

(30,021)

 

 

Administration costs

(160,623)

(165,581)

(318,630)

 

 

 

Operating loss

(153,334)

(185,994)

(365,971)

 

(Loss)/gain on disposal of intangible asset

-

-

30,658

 

Interest receivable

11

39

61

 

 

Loss before income tax

(153,323)

(185,955)

(335,252)

 

Income tax

 

-

-

-

 

Loss for the period attributable to equity

holders of the parent

 

(153,323)

 

(185,955)

 

(335,252)

 

 

Loss per share - basic and fully diluted (pence) (Note 2)

(0.004)

(0.005)

(0.009)

 

 

 

 

Consolidated Statement of Comprehensive Income

for the six months to 31 March 2022

 

 

 

 

 

 

Six months

to 31 March

2022

Unaudited

 

Six months

to 31 March

2021

Unaudited

 

 

Twelve months

to 30 September

2021

Audited

£

£

£

 

 

Loss for the period

(153,323)

(185,955)

(335,252)

 

Other comprehensive income:

 

 

 

Items that could be reclassified subsequently to the income statement:

 

 

 

Foreign exchange translation differences on foreign currency net investments in subsidiaries

 

61,117

 

(127,182)

 

(86,770)

 

 

 

 

 

61,117

(127,182)

(86,770)

 Items that will not be reclassified to the Income Statement:

 

 Changes in the fair value of equity investments

 

(14,282)

 

758

 

(9,651)

 

 

 

(14,282)

758

(9,651)

 Total comprehensive loss for the period attributable to equity holders of the parent

 

 

(106,488)

 

 

(312,379)

 

 

(431,673)

 

   

 

Consolidated Statement of Financial Position

as at 31 March 2022

 

 

 

As at

31 March

2022

Unaudited

 

 

As at

31 March

2021

Unaudited

 

 

As at

30 September

2021

Audited

 

£

 

£

£

 

Non-current assets

Intangible assets

2,228,941

1,997,911

2,133,137

Right of use assets

11,603

15,178

13,423

Other investments

49,553

19,614

63,503

 

 

 

2,290,097

2,032,703

2,210,063

 

 

Current assets

 

Receivables

147,358

130,521

130,805

Cash and cash equivalents

183,923

637,834

371,740

 

 

331,281

768,355

502,545

 

 

Current liabilities

Trade and other payables

 

(103,178)

 

(93,723)

 

(100,861)

Lease liability

(1,171)

(2,248)

(2,300)

 

Net current assets

226,932

672,384

399,384

 

Non-Current liabilities

Lease liability

 

(3,632)

 

(4,553)

 

(4,715)

Reclamation Liability

(24,458)

(25,792)

(26,665)

 

(28,090)

(30,345)

(31,380)

 

 

 

Net assets

2,488,939

2,674,742

2,578,067

 

 

Equity

 

Called up share capital

3,711,086

3,695,860

3,701,805

Share premium account

5,683,695

5,666,997

5,675,616

Share warrant reserve

39,015

40,774

40,164

Fair value reserve

18,820

43,511

33,102

Foreign currency reserve

23,786

(77,743)

(37,331)

Accumulated losses

(6,987,463)

(6,694,657)

(6,835,289)

 

 

Equity attributable to owners of the parent

2,488,939

2,674,742

2,578,067

 

 

 

 

 

 

 

Consolidated Statement of Changes in Equity

 

 

 

Share

capital

 

Share

premium

account

 

Share

warrant reserve

 

Fair

value

reserve

 

Foreign

currency

reserve

 

 

 Accumulated

losses

 

 

 

Total

 

£

£

£

£

£

£

£

At 30 September 2020

3,677,997

5,655,781

33,893

42,753

49,439

(6,513,429)

2,946,434

Loss for the period

-

-

-

-

-

(185,955)

(185,955)

Change in fair value

-

-

-

758

-

-

758

Exchange differences

-

-

-

-

(127,182)

-

(127,182)

Total comprehensive

 

 

 

 

loss for the period

-

-

-

758

(127,182)

(185,955)

(312,379)

Share issue

17,863

11,216

-

-

-

-

29,079

Share based payments expense

-

-

11,608

-

-

-

11,608

Transfer of expired warrants

-

-

(4,727)

-

-

4,727

-

At 31 March 2021

3,695,860

5,666,997

40,774

43,511

(77,743)

(6,694,657)

2,674,742

Loss for the period

-

-

-

-

-

(149,298)

(149,298)

Change in fair value

-

-

-

(10,409)

-

-

(10,409)

Exchange differences

-

-

-

-

40,412

-

40,412

Total comprehensive

-

 

 

loss for the period

-

-

-

(10,409)

40,412

(149,298)

(119,295)

Share issue

5,945

8,619

-

-

-

-

14,564

Share based payments expense

-

-

8,056

-

-

-

8,056

Transfer of expired warrants

-

-

(8,666)

-

-

8,666

-

At 30 September 2021

3,701,805

5,675,616

40,164

33,102

(37,331)

(6,835,289)

2,578,067

Loss for the period

-

-

-

-

-

(153,323)

(153,323)

Change in fair value

-

-

-

(14,282)

-

-

(14,282)

Exchange differences

-

-

-

-

61,117

-

61,117

Total comprehensive

loss for the period

-

-

-

(14,282)

61,117

(153,323)

(106,488)

Share issue

9,281

8,079

-

-

-

-

17,360

Share based payments expense

-

-

-

-

-

-

-

Transfer of expired warrants

-

-

(1,149)

-

-

1,149

-

At 31 March 2022

3,711,086

5,683,695

39,015

18,820

23,786

(6,987,463)

2,488,939

Consolidated Statement of Cash Flows

for the six months to 31 March 2022

 

 

Six months

to 31 March

2022

Unaudited

Six months

to 31 March

2021

Unaudited

 

Twelve months

to 30 September

2021

Audited

 

£

£

£

Operating activity

 

Operating Loss

(153,323)

(185,994)

(335,313)

Depreciation/interest charge

2,285

2,250

4,744

Share based payment charge

-

11,608

19,663

Shares issued in settlement of outstanding salaries

16,685

16,254

30,818

Shares issued via exercise of warrants

675

-

12,825

Impairment of deferred exploration asset

-

7,428

30,021

Disposal of exploration assets

-

-

40,480

Non cash addition of equity investments

-

-

(45,675)

Reclamation provision

(2,950)

-

(26,665)

(Increase)/decrease in receivables

(16,553)

(78,542)

(78,825)

Increase/(decrease) in trade and other payables

2,317

3,046

10,184

 

Net cash outflow from operating activity

(150,864)

(223,950)

(337,743)

 

Investing activity

 

 

Interest received

11

39

60

Receipts from disposal of exploration assets

-

-

20,000

Water lease payments

(2,437)

(2,325)

(2,378)

Project development expenditures

(37,145)

(247,797)

(391,061)

 

Net cash outflow from investing activity

(39,571)

(250,083)

(373,379)

 

Financing activity

 

 

 

Issue of share capital (net of expenses)

675

12,825

-

 

Net cash inflow from financing activity

675

12,825

-

 

Net (decrease)/increase in cash and cash equivalents

(189,760)

(461,208)

(711,122)

 

Cash and cash equivalents at start of period

371,740

1,089,417

1,089,417

Exchange differences

1,943

 

9,625

(6,555)

 

 

Cash and cash equivalents at end of period

 

 183,923

 

 637,834

 

371,740

 

 

Notes to the Interim Statement

 

1. Basis of preparation

 

The consolidated interim financial information has been prepared in accordance with the accounting policies that are expected to be adopted in the Group's full financial statements for the year ending 30 September 2022 which are not expected to be significantly different to those set out in Note 1 of the Group's audited financial statements for the year ended 30 September 2021. These are based on the recognition and measurement requirements of applicable law and International Accounting Standards in conformity with the Companies Act 2006. The financial information has not been prepared (and is not required to be prepared) in accordance with IAS 34. The accounting policies have been applied consistently throughout the Group for the purposes of preparation of this financial information.

 

The financial information in this statement relating to the six months ended 31 March 2022 and the six months ended 31 March 2021 has neither been audited nor reviewed by the Independent Auditor pursuant to guidance issued by the Auditing Practices Board. The financial information presented for the year ended 30 September 2021 does not constitute the full statutory accounts for that period. The Annual Report and Financial Statements for the year ended 30 September 2021 have been filed with the Registrar of Companies. The Independent Auditor's Report on the Annual Report and Financial Statements for the year ended 30 September 2021 was unqualified, although it did draw attention to matters by way of emphasis in relation to going concern.

 

The directors prepare annual budgets and cash flow projections for a 15-month period. These projections include the proceeds of future fundraising necessary within the period to meet the Company's and the Group's planned discretionary project expenditures and to maintain the Company and the Group as a going concern. Although the Company has been successful in raising finance in the past, there is no assurance that it will obtain adequate finance in the future. These factors represent a material uncertainty related to events or conditions which may cast significant doubt on the entity's ability to continue as a going concern and, therefore, that it may be unable to realise its assets and discharge its liabilities in the normal course of business. However, the directors have a reasonable expectation that they will secure additional funding when required to continue meeting corporate overheads and exploration costs for the foreseeable future and therefore believe that the going concern basis is appropriate for the preparation of the financial statements.

 

 

2. Loss per share

 

Loss per share has been calculated on the attributable loss for the period and the weighted average number of shares in issue during the period.

 

 

Six months

 to 31 March

2022

Unaudited

 

 

Six months

to 31 March

2021

Unaudited

 

 

Twelve months

to 30 September

2021

Audited

 

 

 

Loss for the period (£)

(153,323)

(185,955)

(335,252)

 

Weighted average shares in issue (No.)

 

3,705,826,898

 

3,383,046,491

 

3,693,084,489

 

Basic and diluted loss per share (pence)

(0.004)

(0.005)

(0.009)

 

The loss attributable to ordinary shareholders and weighted average number of shares for the purpose of calculating the diluted earnings per share are identical to those used for the basic earnings per share. This is because the exercise of share warrants would have the effect of reducing the loss per share and is therefore not dilutive under the terms of IAS33.

 

 

 

 

 

3. Share capital

 

During the six months to 31 March 2022 the following share issues took place:

 

An issue of 8,781,779 Ordinary Shares of 0.1p at 0.19p per share to three directors, for a total consideration of £16,685, in satisfaction of a portion of outstanding directors' fees (10 January 2022).

 

An issue of 500,000 Ordinary Shares of 0.1p at 0.135p per share for a total consideration of £675, following an exercise of warrants (31 January 2022).

 

The total number of shares in issue on 31 March 2022 was 3,711,086,466 (30 September 2021: 3,701,804,687).

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR USVARUSUVUAR
Date   Source Headline
19th Aug 20147:00 amRNSFurther Diamond results, Cue Project
15th Aug 201412:21 pmRNSHolding(s) in Company
15th Aug 20147:00 amRNSFurther positive diatomite testwork results
12th Aug 20147:00 amRNSCue Diamond and Corona Gold Projects - Update
30th Jun 20147:00 amRNSProject Updates
19th May 20147:00 amRNSHalf Yearly Report
12th May 20147:00 amRNSPositive Testwork Results - County Line Diatomite
28th Apr 20147:00 amRNSDrilling Update
31st Mar 20148:00 amRNSTotal Voting Rights
27th Mar 20147:00 amRNSCue Diamond and Strike Copper Projects - Update
19th Mar 201412:38 pmRNSHolding(s) in Company
19th Mar 20149:59 amRNSHolding(s) in Company
17th Mar 201412:00 pmRNSIssue of Equity
3rd Mar 20147:00 amRNSProject Update
19th Feb 201412:24 pmRNSResult of AGM
19th Feb 20147:00 amRNSUPDATED PRESENTATION
17th Feb 20147:00 amRNSNew Projects - Nevada
13th Feb 20147:00 amRNSCue Diamond Project - Update
17th Jan 20149:38 amRNSPosting of Annual Report
15th Jan 20147:00 amRNSShare and Warrant Issue
8th Jan 201412:18 pmRNSDirector Share Purchase
12th Dec 201311:32 amRNSFinal Results
13th Nov 20133:16 pmRNSHolding(s) in Company
6th Nov 20135:35 pmRNSIssue of Equity
30th Sep 20137:00 amRNSFurther Positive Diamond Results
30th Aug 20137:00 amRNSTotal Voting Rights
7th Aug 20138:00 amRNSAdmission to trading and Total Voting Rights
1st Aug 201312:14 pmRNSIssue of Equity
25th Jul 20137:00 amRNSNew gold projects and Cue Diamond project update
15th May 201311:53 amRNSHalf Yearly Report
25th Mar 20137:00 amRNSPositive Diamond Results
19th Feb 20133:39 pmRNSResult of AGM
18th Feb 20137:00 amRNSCue Diamond Project Update
29th Jan 20131:13 pmRNSUpdate re drilling results
22nd Jan 20137:00 amRNSCue Diamond Sampling Results
4th Jan 20137:00 amRNSDirector Share Purchase & Issue of Equity
20th Dec 20127:00 amRNSGrant of warrants
12th Dec 20121:30 pmRNSFinal Results
3rd Dec 20127:00 amRNSCue Diamond Project - new Kimberlite Occurrences
12th Nov 20127:00 amRNSEquity Finance Facility Warrants Pricing
1st Nov 20127:00 amRNSStudy Update - Derryginagh Barite Project
25th Oct 20127:00 amRNS£3m Equity Finance Facility Secured
23rd Oct 20127:00 amRNSCue 1 Kimberlite confirmed diamondiferous
22nd Oct 20127:00 amRNSResponse to Press Comment & Market Update
25th Sep 20127:00 amRNSDerryginagh Project Update
6th Sep 20127:00 amRNSCue Project Update
31st Aug 20129:15 amRNSHolding(s) in Company
21st Aug 20127:00 amRNSProject Update
30th Jul 20124:48 pmRNSIssue of Equity
31st May 20127:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.